Ghent University Academic Bibliography

Advanced

Predicting the outcome of ankylosing spondylitis therapy

Nathan Vastesaeger, Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, Ben Dijkmans, Piet Geusens, Bert Vander Cruyssen UGent, et al. (2011) ANNALS OF THE RHEUMATIC DISEASES. 70(6). p.973-981
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
Immunology, Biochemistry, Genetics and Molecular Biology(all), Immunology and Allergy, Rheumatology, DISEASE-ACTIVITY INDEX, NECROSIS FACTOR TREATMENT, PLACEBO-CONTROLLED TRIAL, MAJOR CLINICAL-RESPONSE, ACTIVITY SCORE ASDAS, ANTI-TNF THERAPY, INFLIXIMAB, SAFETY, EPIDEMIOLOGY, IMPROVEMENT
journal title
ANNALS OF THE RHEUMATIC DISEASES
Ann. Rheum. Dis.
volume
70
issue
6
pages
973 - 981
Web of Science type
Article
Web of Science id
000290149900016
JCR category
RHEUMATOLOGY
JCR impact factor
8.727 (2011)
JCR rank
1/29 (2011)
JCR quartile
1 (2011)
ISSN
0003-4967
DOI
10.1136/ard.2010.147744
language
English
UGent publication?
yes
classification
A1
additional info
correction published in: Ann. Rheum. Dis. (2012) 71(8), 1434 ; DOI 10.1136/ard.2010.147744corr1
copyright statement
I have transferred the copyright for this publication to the publisher
id
8500055
handle
http://hdl.handle.net/1854/LU-8500055
date created
2016-12-20 10:45:29
date last changed
2017-01-18 15:26:29
@article{8500055,
  author       = {Vastesaeger, Nathan and van der Heijde, D{\'e}sir{\'e}e and Inman, Robert D and Wang, Yanxin and Deodhar, Atul and Hsu, Benjamin and Rahman, Mahboob U and Dijkmans, Ben and Geusens, Piet and Vander Cruyssen, Bert and Collantes, Eduardo and Sieper, Joachim and Braun, J{\"u}rgen},
  issn         = {0003-4967},
  journal      = {ANNALS OF THE RHEUMATIC DISEASES},
  keyword      = {Immunology,Biochemistry,Genetics and Molecular Biology(all),Immunology and Allergy,Rheumatology,DISEASE-ACTIVITY INDEX,NECROSIS FACTOR TREATMENT,PLACEBO-CONTROLLED TRIAL,MAJOR CLINICAL-RESPONSE,ACTIVITY SCORE ASDAS,ANTI-TNF THERAPY,INFLIXIMAB,SAFETY,EPIDEMIOLOGY,IMPROVEMENT},
  language     = {eng},
  number       = {6},
  pages        = {973--981},
  title        = {Predicting the outcome of ankylosing spondylitis therapy},
  url          = {http://dx.doi.org/10.1136/ard.2010.147744},
  volume       = {70},
  year         = {2011},
}

Chicago
Vastesaeger, Nathan, Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, et al. 2011. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” Annals of the Rheumatic Diseases 70 (6): 973–981.
APA
Vastesaeger, N., van der Heijde, D., Inman, R. D., Wang, Y., Deodhar, A., Hsu, B., Rahman, M. U., et al. (2011). Predicting the outcome of ankylosing spondylitis therapy. ANNALS OF THE RHEUMATIC DISEASES, 70(6), 973–981.
Vancouver
1.
Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, et al. Predicting the outcome of ankylosing spondylitis therapy. ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):973–81.
MLA
Vastesaeger, Nathan, Désirée van der Heijde, Robert D Inman, et al. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” ANNALS OF THE RHEUMATIC DISEASES 70.6 (2011): 973–981. Print.